MRAP | Melanocortin 2 receptor accessory protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
ANO4 | Anoctamin 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ARC | Activity-regulated cytoskeleton-associated protein | Predicted intracellular proteins
| | | | | Group enriched |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Group enriched |
ASB4 | Ankyrin repeat and SOCS box containing 4 | Predicted intracellular proteins
| | | | | Group enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
BEX1 | Brain expressed, X-linked 1 | Predicted intracellular proteins
| | | | | Group enriched |
BRINP2 | Bone morphogenetic protein/retinoic acid inducible neural-specific 2 | Predicted secreted proteins
| | | | | Group enriched |
CACNA1B | Calcium channel, voltage-dependent, N type, alpha 1B subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
CALY | Calcyon neuron-specific vesicular protein | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | Predicted intracellular proteins
| | | | | Group enriched |
CDH12 | Cadherin 12, type 2 (N-cadherin 2) | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CDH18 | Cadherin 18, type 2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDH22 | Cadherin 22, type 2 | Predicted membrane proteins
| | | | | Group enriched |
CHRNB4 | Cholinergic receptor, nicotinic, beta 4 (neuronal) | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
CLRN1 | Clarin 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CPLX2 | Complexin 2 | Predicted intracellular proteins
| | | | | Group enriched |
CYP2W1 | Cytochrome P450, family 2, subfamily W, polypeptide 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DNER | Delta/notch-like EGF repeat containing | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
FAM135B | Family with sequence similarity 135, member B | Predicted intracellular proteins
| | | | | Group enriched |
FAM166B | Family with sequence similarity 166, member B | Predicted intracellular proteins
| | | | | Group enriched |
FAM19A3 | Family with sequence similarity 19 (chemokine (C-C motif)-like), member A3 | Predicted secreted proteins
| | | | | Group enriched |
FAM43B | Family with sequence similarity 43, member B | Predicted intracellular proteins
| | | | | Group enriched |
FBLL1 | Fibrillarin-like 1 | Predicted intracellular proteins
| | | | | Group enriched |
FEV | FEV (ETS oncogene family) | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
FNDC9 | Fibronectin type III domain containing 9 | Predicted membrane proteins
| | | | | Group enriched |
FRMD5 | FERM domain containing 5 | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FRRS1L | Ferric-chelate reductase 1-like | Predicted membrane proteins
| | | | | Group enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
GABRQ | Gamma-aminobutyric acid (GABA) A receptor, theta | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
GALNT13 | Polypeptide N-acetylgalactosaminyltransferase 13 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
GALR1 | Galanin receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
GCGR | Glucagon receptor | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GPR83 | G protein-coupled receptor 83 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GPR98 | G protein-coupled receptor 98 | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
GRIK1 | Glutamate receptor, ionotropic, kainate 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
IGLON5 | IgLON family member 5 | Predicted secreted proteins
| | | | | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | Predicted intracellular proteins
| | | | | Group enriched |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
KCNMB4 | Potassium large conductance calcium-activated channel, subfamily M, beta member 4 | Predicted membrane proteins
| | | | | Group enriched |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LRRC38 | Leucine rich repeat containing 38 | Predicted membrane proteins
| | | | | Group enriched |
LRRTM3 | Leucine rich repeat transmembrane neuronal 3 | Predicted membrane proteins
| | | | | Group enriched |
LUZP2 | Leucine zipper protein 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
LUZP6 | Leucine zipper protein 6 | Predicted intracellular proteins
| | | | | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |